tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

Neurizon Therapeutics Reports Significant Loss Amidst Strategic Shift
Company AnnouncementsNeurizon Therapeutics Reports Significant Loss Amidst Strategic Shift
6d ago
Neurizon Therapeutics to Present Half-Year Results and FDA Feedback on ALS Treatment
PremiumCompany Announcements
Neurizon Therapeutics to Present Half-Year Results and FDA Feedback on ALS Treatment
6d ago
Neurizon Receives FDA Guidance on NUZ-001 IND Application
PremiumCompany Announcements
Neurizon Receives FDA Guidance on NUZ-001 IND Application
6d ago
Neurizon Therapeutics Announces Half-Year Update Webinar
PremiumCompany Announcements
Neurizon Therapeutics Announces Half-Year Update Webinar
12d ago
Director’s Interest Update at Neurizon Therapeutics
PremiumCompany Announcements
Director’s Interest Update at Neurizon Therapeutics
16d ago
Neurizon Secures US Patent for NUZ-001, Strengthening Market Position
PremiumCompany AnnouncementsNeurizon Secures US Patent for NUZ-001, Strengthening Market Position
18d ago
Neurizon Therapeutics Issues Unlisted Options in Employee Incentive Scheme
Premium
Company Announcements
Neurizon Therapeutics Issues Unlisted Options in Employee Incentive Scheme
23d ago
Neurizon Therapeutics Advances ALS Treatment with Promising Results and Regulatory Milestones
Premium
Company Announcements
Neurizon Therapeutics Advances ALS Treatment with Promising Results and Regulatory Milestones
25d ago
Neurizon Therapeutics Faces FDA Hold on NUZ-001 IND Application
PremiumCompany Announcements
Neurizon Therapeutics Faces FDA Hold on NUZ-001 IND Application
1M ago
Neurizon Therapeutics Enhances Shareholder Services with Registry Switch
PremiumCompany Announcements
Neurizon Therapeutics Enhances Shareholder Services with Registry Switch
1M ago
Neurizon Therapeutics Expands Shareholding Amid ALS Treatment Push
PremiumCompany Announcements
Neurizon Therapeutics Expands Shareholding Amid ALS Treatment Push
2M ago
Neurizon Therapeutics Lists New Shares on ASX
PremiumCompany Announcements
Neurizon Therapeutics Lists New Shares on ASX
2M ago
Neurizon Therapeutics Moves Forward with ALS Trial
PremiumCompany AnnouncementsNeurizon Therapeutics Moves Forward with ALS Trial
2M ago
Neurizon Secures EU Orphan Status for ALS Drug
Premium
Company Announcements
Neurizon Secures EU Orphan Status for ALS Drug
2M ago
Neurizon Therapeutics Sets Positive 2025 Outlook
Premium
Company Announcements
Neurizon Therapeutics Sets Positive 2025 Outlook
2M ago
Neurizon Therapeutics Hosts Insightful Webinar on Future Plans
PremiumCompany Announcements
Neurizon Therapeutics Hosts Insightful Webinar on Future Plans
3M ago
Neurizon Therapeutics Expands Share Issuance Amid ALS Focus
PremiumCompany Announcements
Neurizon Therapeutics Expands Share Issuance Amid ALS Focus
3M ago
Neurizon Therapeutics Boosts ASX Presence with New Securities
PremiumCompany Announcements
Neurizon Therapeutics Boosts ASX Presence with New Securities
3M ago
Neurizon Therapeutics Updates Securities Trading Policy
PremiumCompany Announcements
Neurizon Therapeutics Updates Securities Trading Policy
3M ago
Neurizon Therapeutics Corrects Announcement on ALS Drug
PremiumCompany AnnouncementsNeurizon Therapeutics Corrects Announcement on ALS Drug
3M ago
Neurizon Therapeutics Explores Promising ALS Treatment
Premium
Company Announcements
Neurizon Therapeutics Explores Promising ALS Treatment
3M ago
Neurizon Therapeutics Announces Promising ALS Drug Results
Premium
Company Announcements
Neurizon Therapeutics Announces Promising ALS Drug Results
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >